A commentary on ‘development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (searcher): a multi-institutional observational study’ (Int J Surg 2022;106:106842)-Reference-Cited by-同舟云学术

A commentary on ‘development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (searcher): a multi-institutional observational study’ (Int J Surg 2022;106:106842)

Published:2023-02 Issue:2 Volume:109 Page:204-205
ISSN:1743-9191
Container-title:International Journal of Surgery
language:en
Short-container-title:

Author:

Huo Teh-Ia¹²³^ORCID,Ho Shu-Yein²⁴,Liao Jia-I⁵²

Affiliation:

1. Department of Medical Research

2. School of Medicine

3. Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei

4. Division of Gastroenterology and Hepatology, Min-Sheng General Hospital, Taoyuan, Taiwan

5. Department of Medicine, Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Reference8 articles.

1. Development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (SEARCHER): A multi-institutional observational study;Chen;Int J Surg,2022

2. Predictors of long-term recurrence and survival after resection of HBV-related hepatocellular carcinoma: the role of HBsAg;Lee;Am J Cancer Res,2021

3. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma;Tsai;Surgery,2000

4. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy;Imamura;J Hepatol,2003

5. Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation;Rizzi;Gastroenterology,1994